The reopening of the IPO window in late 2025 has forced a reckoning for the cohort of private companies that achieved "decacorn" status—valuations of $10 billion or more—during the low-interest-rate era. As these companies prepare to face public market scrutiny, many are discovering that the valuations assigned by their last private funding rounds bear little resemblance to what public investors are willing to pay. The resulting markdowns are reshaping the venture capital landscape and raising uncomfortable questions about private market price discovery.
The numbers tell a stark story. Of the 47 decacorns that raised private funding in 2021 at valuations exceeding $10 billion, only 12 have successfully completed IPOs. Among those that did, the average discount to their last private valuation exceeded 35%. Several high-profile companies that were once valued at $20 billion or more now trade at market capitalizations below $8 billion. For venture capital firms that marked their portfolios at those inflated values, the implications for fund returns are severe.
The dynamics that created the decacorn phenomenon are well understood. Abundant capital seeking limited opportunities drove valuations upward, while founders—flush with cash and eager to delay the transparency requirements of public markets—accepted generous terms that often included ratchets and other downside protections for late-stage investors. These structural features created a divergence between the headline valuation and the underlying enterprise value that only becomes apparent when companies face the public markets.
Public market investors are applying a fundamentally different framework. Rather than paying for growth at any price, they are demanding evidence of unit economics, a clear path to profitability, and defensible competitive positions. Companies that expanded rapidly by burning cash are being valued at steep discounts to those that achieved similar scale with operating discipline. The Rule of 40—the principle that a company's revenue growth rate plus profit margin should exceed 40%—has become a minimum threshold rather than an aspirational target.
For the decacorns that remain private, the path forward is uncomfortable. Raising additional private funding at a valuation below the previous round—a "down round"—triggers antidilution provisions that transfer equity from founders and early employees to later investors. Some companies are attempting to avoid this outcome by extending their runways through cost cutting, delaying any need for fresh capital. Others are pursuing acquisitions, seeking strategic buyers who may value their technology or talent more generously than public markets would.
The implications extend beyond individual companies to the venture capital ecosystem as a whole. Limited partners in venture funds—the pension funds, endowments, and family offices that provide the capital—are recalibrating their commitments based on realized returns rather than paper markups. Several large venture firms have seen their fundraising timelines extend significantly as LPs demand evidence that portfolio companies can actually achieve exits at or above their marked valuations.
Looking forward, the decacorn correction is likely to impose healthier discipline on the private markets. Founders raising capital in 2026 are facing more realistic valuation expectations and investors who prioritize sustainable growth over hyperbolic expansion. While this adjustment is painful for those caught on the wrong side, it sets the stage for a more rational allocation of capital to private companies. The excesses of 2021 are being corrected, and the companies that emerge from this period will be stronger for having endured it.